Partial Sleep Restriction in Chronic Low Back Pain: A Feasibility Study
1 other identifier
observational
50
1 country
1
Brief Summary
Our goal is to observational study is to determine feasibility of partial sleep restriction in individuals with CLBP+I and correlation findings with features of central sensitization.
- Identify feasibility of sleep restriction protocol
- Identify correlation between less sleep and central sensitization Sleep will be monitored for 2 weeks (baseline sleep monitoring period). Then participants will be asked to restrict their sleep to 80% of their normal sleep duration for 5 nights (sleep restriction period). Then sleep will be monitored again for 2 weeks (sleep recovery period).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 14, 2022
CompletedFirst Submitted
Initial submission to the registry
July 20, 2022
CompletedFirst Posted
Study publicly available on registry
June 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJune 6, 2025
June 1, 2025
3.5 years
July 20, 2022
June 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Sleep Measures
Daily electronic sleep diaries
Through study completion, up to 5 weeks
Sleep Measures
Insomnia Severity Index (ISI)
Through study completion, up to 5 weeks
Sleep Measures
Pittsburgh Sleep Quality
Through study completion, up to 5 weeks
Pain Measures
Daily pain diaries
Through study completion, up to 5 weeks
Pain Measures
SF-McGill (MPQ),
Through study completion, up to 5 weeks
Secondary Outcomes (13)
Sleep Measures
Through study completion, up to 5 weeks
Pain Measures
Through study completion, up to 5 weeks
Pain Measures
Through study completion, up to 5 weeks
Pain Measures
Through study completion, up to 5 weeks
Pain Measures
Through study completion, up to 5 weeks
- +8 more secondary outcomes
Study Arms (2)
Healthy Control
Healthy control group will consist of those without any pain and sleep issues.
Chronic Low Back Pain (CLBP)
CLBP group will consist of those with LBP. Individuals with CLBP who also experience minor sleep issues are also eligible.
Interventions
Return to normal sleep observation.
Eligibility Criteria
We will primarily recruit patients via word of mouth, by placing study flyers throughout KU hospital and KUMC and social media e.g. broadcast, facebook, etc. We may also use KUMC's CTSA Frontiers patient registry to recruit participants with LBP. Attach is a copy of study flyer.
You may qualify if:
- 25-65 years old individuals
- With or without insomnia
- CLBP (LBP for at least 3 months with or without referred or radiating leg pain; pain intensity 1 or greater on 0 - 10 VAS scale
- likely to participate in all scheduled evaluations and study procedures by self-report
- agrees to abide by safely protocol e.g. not to drive or operate heavy machinery and perform heavy labor work, during the sleep-restriction period
You may not qualify if:
- spine compression, tumor, infection, history of spine surgery
- neurological conditions such as stroke, Parkinson's disease, Alzheimer's disease or other cognitive impairments.
- pregnancy
- known untreated sleep disorder (such as current sleep apnea or current restless leg syndrome) screened by the following scales to ensure insomnia symptoms are due to insomnia and not another common sleep disorders:
- Those with increased risk of sleep apnea
- Increased risk of restless leg syndrome on RLS-Diagnosis Index
- Increased risk of circadian rhythm sleep-wake disorder
- Increased risk of parasomnia
- Moderate level of depression identified by Patient Health Questionnaire (PHQ-9)
- Moderate level of anxiety identify by Generalized Anxiety Disorder (GAD-7)
- history of drug or alcohol abuse as defined by DSM-IV criteria within the last 2 years
- severe mental illness such as schizophrenia or bipolar disorder
- developmental history of learning disability or attention-deficit/hyperactivity disorder
- is currently receiving CBT-I, physical therapy or chiropractic treatment
- history of spinal surgery
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neena Sharma
university
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 5 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 20, 2022
First Posted
June 6, 2025
Study Start
July 14, 2022
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
June 6, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share